Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: Outcome of 7 Patients from the Bonn Cohort

Liver Transplantation

Volumn 11, Issue 12, 2005, Pages 1515-1521

  Vogel, Martin ^a   Voigt, Esther ^a   Schäfer, Nico ^a   Goldmann, Georg ^a   Schwarz, Nicolas ^a   Kalff, Jörg C ^a   Sauerbruch, Tilman ^a   Wolff, Martin ^a   Rockstroh, Jürgen Kurt ^a   Spengler, Ulrich ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CALCINEURIN INHIBITOR; CD4 ANTIGEN; CYCLOSPORIN A; DOXORUBICIN; GANCICLOVIR; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; LOPINAVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NELFINAVIR; PEGINTERFERON; PEGINTERFERON ALPHA2A; PREDNISONE; PROTEINASE INHIBITOR; RIBAVIRIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR DISOPROXIL; VIRUS RNA; ZIDOVUDINE;

ABSENCE OF SIDE EFFECTS; ACUTE GRAFT REJECTION; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; FEMALE; GERMANY; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REINFECTION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; FOLLOW-UP STUDIES; GRAFT REJECTION; HIV; HIV ANTIBODIES; HIV SEROPOSITIVITY; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 29744434264     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20498     Document Type: Article

References (23)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Aminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-29.
2. Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA 2001;285:1308-1315.
3. Martin-Carbonero L, Soriano V, Valencia E, Garcia-Samaniego J, Lopez M, Gonzalez-Lahoz J. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res Hum Retroviruses 2001;17:1467-1471.
4. Rosenthal E, Poiree M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003;17:1803-1809.
5. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003;76:370-375.
6. Rufi G, Barcena R, Vargas V, Valdivieso A, Miro JM, Salcedo M, et al. Orthotopic liver transplantation in 15 HIV-1-infected patients: evaluation of Spanish experience in the HAART-era (2002-2003). San Francisco, CA: 11th Conference on Retroviruses and Opportunistic Infections, 2004.
7. Duclos-Vallee JC, Vittecoq D, Teicher E, Feray C, Roque-Alfonso AM, Lombes A, et al. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol 2005;42:341-349.
8. Samuel D, Duclos Vallee JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol 2003;39: 3-6.
9. Radecke K, Fruhauf NR, Miller M, Ross B, Koditz R, Malago M, Broelsch CE, Gerken G, Treichel U. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005;25(1):101-108.
10. Prachalias AA, Pozniak A, Taylor C, Srinivasan P, Muiesan P, Wendon J. et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001;72:1684-1688.
11. Ragni MV, Belle SH, Im K, Neff G, Roland M, Stack P, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003;188:1412-1420.
12. Nowak P, Schvarcz R, Ericzon BG, Flamholc L, Sonnerborg A. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2003;19:13-19.
13. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003;9:239-247.
14. Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004;10:1271-1278.
15. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1.
16. UNOS: MELD/PELD calculator documentation. Web resource, 2004. http://www.unos.org/waitlist/includes_local/pdfs/meld_peld_calculator.pdf
17. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
18. Vogel M, Voigt E, Michaelis HC, Sudhop T, Wolff M, Turler A, et al. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver Transpl 2004;10:939-944.
19. Teicher E, Vittecoq D, Duclos-Vallés J, Azulay D, Castaing D, Bismuth H, et al. Liver transplantation in HIV-HCV co-infected patients. San Francisco, CA: 11th Conference on Retroviruses and Opportunistic Infections, 2004.
20. Qurishi N, Kreuzberg C, Luchters G, Effenberger W, Kupfer B, Sauerbruch T, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003;362:1708-1713.
21. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl 2003;9: S28-S34.
22. Wiesner RH, Sorrell M, Villamil F. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 2003;9:S1-S9.
23. Roland M, Stablein D, Carlson L, Frassetto L, Murphy B, Keller M, et al. 1- to 3-year outcomes in HIV-infected liver and kidney transplant recipients. Boston, MA: 12th Conference on Retroviruses and Opportunistic Infections, 2005.